NanoViricides
NNVC
#10526
Rank
ยฃ27.3 M
Marketcap
ยฃ1.07
Share price
7.51%
Change (1 day)
-16.37%
Change (1 year)

NanoViricides (NNVC) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : ยฃ0.89 Million

According to NanoViricides's latest financial reports the company's total liabilities are ยฃ0.89 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NanoViricides - Total liabilities on balance sheet (from 2006 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30ยฃ1.6 M371.38%
2022-06-30ยฃ0.33 M33.7%
2021-06-30ยฃ0.25 M-85.41%
2020-06-30ยฃ1.74 M-22.42%
2019-06-30ยฃ2.24 M236.03%
2018-06-30ยฃ0.66 M-87%
2017-06-30ยฃ5.13 M-49.61%
2016-06-30ยฃ10.19 M28.93%
2015-06-30ยฃ7.9 M-33.99%
2014-06-30ยฃ11.97 M116.83%
2013-06-30ยฃ5.52 M386.92%
2012-06-30ยฃ1.13 M210.02%
2011-06-30ยฃ0.36 M-77.57%
2010-06-30ยฃ1.63 M421.15%
2009-06-30ยฃ0.31 M-39.2%
2008-06-30ยฃ0.51 M21.25%
2007-06-30ยฃ0.42 M-47.95%
2006-06-30ยฃ0.81 M2085.81%
2005-06-30ยฃ0.03 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
ยฃ28.12 B 3,159,164.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ65.65 B 7,375,101.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ48.86 B 5,489,687.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ52.89 B 5,941,523.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
ยฃ0.85 B 96,167.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
ยฃ0.75 B 84,902.35%๐Ÿ‡บ๐Ÿ‡ธ USA